Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe
January 30, 2020 01:56 ET
|
Curetis
BGI Group responds to coronavirus crisis by providing reagent kits for molecular 2019-nCoV testing by next-generation sequencing and RT-PCRAres Genetics to launch next-generation sequencing...
Curetis to Hold Extraordinary General Meeting on March 10, 2020
January 27, 2020 01:53 ET
|
Curetis
Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, January 27, 2020, 08:00 am CET / 02:00 am EDT - Curetis N.V. (the "Company" and together with its subsidiaries...
Curetis To Attend Key Conferences in the First Half of 2020
January 23, 2020 03:50 ET
|
Curetis
Amsterdam, the Netherlands, and Holzgerlingen, Germany, January 23, 2020, 10:00 am CET - Curetis N.V. (the "Company" and, together with its subsidiaries, "Curetis"), a developer of next-level...
Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.
January 14, 2020 01:58 ET
|
Curetis
Panel also includes atypical pathogens such as Pneumocystis jiroveciiLRT BAL Panel expected to substantially increase total addressable market for Unyvero System in the U.S. Amsterdam, the...
Curetis Receives U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens
December 20, 2019 17:32 ET
|
Curetis
Broad Unyvero LRT BAL panel also includes atypical pathogens such as Pneumocystis jiroveciiClearance expected to substantially increase total addressable market for Unyvero System in the...
Ares Genetics, a Curetis Group Company, Joins NVIDIA Inception and AWS Activate Programs
December 10, 2019 01:58 ET
|
Curetis
Ares Genetics selected for NVIDIA and AWS programs to accelerate commercialization of its AI-powered Universal Pathogenome Assay – ARESupaNVIDIA Inception program accelerates start-ups that...
Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize
November 25, 2019 04:02 ET
|
Curetis
Prize awarded by the Vienna Economic Chamber to the most innovative companies in Vienna Ares Genetics´ awarded in the category Life Sciences for its AI-powered Universal Pathogenome Assay -...
Curetis Expects Near-Term U.S. FDA Decision on 510(k) Clearance of Unyvero LRT for BAL Specimens
November 25, 2019 02:00 ET
|
Curetis
All formal FDA requests for additional information answeredInteractive review ongoing as review nears completion Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA,...
Curetis Publishes Third Quarter and 9-Month Business and Financial Update
November 25, 2019 01:03 ET
|
Curetis
- Signed IVD partnership for Ares Genetics - Progressed implementation of the Curetis - OpGen business combination with S4 filing - More than tripled total contract order volume received...
Curetis Provides Business Update for the First Nine Months of 2019
November 14, 2019 02:00 ET
|
Curetis
- Signed IVD partnership for Ares Genetics - Progressed implementation of the Curetis - OpGen business combination with S4 filing - More than tripled total contract order volume received...